New Triglyceride-Lowering Indications and Bempedoic Acid Approval for Dyslipidemia | Pharmacotherapy Updates | AccessPharmacy | McGraw-Hill Medical

Skip to Main Content

Print
Share
- Email
- Twitter
- Facebook
- Linkedin
- Reddit
Get Citation

Citation

AMA Citation
Marrs JC. Marrs J.C. Marrs, Joel C. "New Triglyceride-Lowering Indications and Bempedoic Acid Approval for Dyslipidemia." Pharmacotherapy Updates, 10 March 2020. McGraw-Hill, New York, NY, 2020. AccessPharmacy. http://accesspharmacy.mhmedical.com/updatesContent.aspx?gbosid=535572&sectionid=241387185

MLA Citation
Marrs JC. Marrs J.C. Marrs, Joel C.. "New Triglyceride-Lowering Indications and Bempedoic Acid Approval for Dyslipidemia." Pharmacotherapy Updates DiPiro JT. DiPiro J.T. DiPiro, Joseph T. New York, NY: McGraw-Hill, 2020, http://accesspharmacy.mhmedical.com/updatesContent.aspx?gbosid=535572&sectionid=241387185.

Download citation file:

RIS (Zotero)

EndNote

BibTex

Medlars

ProCite

RefWorks

Reference Manager

Mendeley

© Copyright
Tools
Clip

Top

GET ACCESS TO THIS RESOURCE

Sign In

Username

Password

Forgot Username? Forgot Password?

Sign in via OpenAthens

Sign in via Shibboleth

Get Free Access Through Your Institution

Contact your institution's library to ask if they subscribe to McGraw-Hill Medical Products.

What is MyAccess?

Use this site remotely
Bookmark your favorite content
Track your self-assessment progress
and more!

GET ACCESS TO THIS RESOURCE

Subscription Options

Pay Per View

Timed Access to all of AccessPharmacy

24 Hour

$34.95 (USD)

48 Hour

$54.95 (USD)

Best Value

AccessPharmacy Full Site: One-Year Individual Subscription

$595 USD

Buy Now

View All Subscription Options

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.

>